Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) - Stock analysts at Zacks Research upped their FY2025 EPS estimates for Phibro Animal Health in a research note issued on Friday, May 23rd. Zacks Research analyst R. Department now forecasts that the company will post earnings of $2.03 per share for the year, up from their prior estimate of $2.02. The consensus estimate for Phibro Animal Health's current full-year earnings is $1.95 per share. Zacks Research also issued estimates for Phibro Animal Health's Q4 2025 earnings at $0.50 EPS, Q3 2027 earnings at $0.59 EPS and FY2027 earnings at $2.32 EPS.
Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last released its quarterly earnings results on Wednesday, May 7th. The company reported $0.63 earnings per share for the quarter, topping the consensus estimate of $0.52 by $0.11. The company had revenue of $347.80 million for the quarter, compared to analysts' expectations of $352.41 million. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%.
Several other research analysts have also issued reports on PAHC. Morgan Stanley raised their price target on shares of Phibro Animal Health from $20.00 to $21.00 and gave the stock an "equal weight" rating in a report on Thursday, May 8th. Barclays upped their price target on Phibro Animal Health from $20.00 to $22.00 and gave the stock an "underweight" rating in a research note on Monday, February 10th. Finally, Wall Street Zen raised shares of Phibro Animal Health from a "hold" rating to a "buy" rating in a research note on Friday, May 9th. Two research analysts have rated the stock with a sell rating, two have assigned a hold rating and one has issued a buy rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Hold" and an average target price of $20.00.
Check Out Our Latest Stock Analysis on PAHC
Phibro Animal Health Trading Up 0.2%
PAHC traded up $0.05 during midday trading on Monday, hitting $24.71. 17,309 shares of the company were exchanged, compared to its average volume of 246,434. Phibro Animal Health has a 1-year low of $16.16 and a 1-year high of $26.55. The company has a quick ratio of 1.37, a current ratio of 3.20 and a debt-to-equity ratio of 2.99. The firm has a market capitalization of $1.00 billion, a P/E ratio of 51.48, a P/E/G ratio of 0.45 and a beta of 0.62. The firm's 50 day moving average price is $20.46 and its 200-day moving average price is $21.90.
Institutional Investors Weigh In On Phibro Animal Health
Several large investors have recently made changes to their positions in the business. Barclays PLC raised its stake in shares of Phibro Animal Health by 25.7% in the third quarter. Barclays PLC now owns 143,337 shares of the company's stock valued at $3,228,000 after buying an additional 29,271 shares during the period. SG Americas Securities LLC increased its holdings in Phibro Animal Health by 7.4% during the 4th quarter. SG Americas Securities LLC now owns 13,162 shares of the company's stock worth $276,000 after acquiring an additional 906 shares during the period. Smith Group Asset Management LLC purchased a new position in shares of Phibro Animal Health during the 4th quarter valued at $541,000. New York State Teachers Retirement System increased its stake in Phibro Animal Health by 16.7% in the 4th quarter. New York State Teachers Retirement System now owns 5,428 shares of the company's stock worth $114,000 after acquiring an additional 775 shares during the last quarter. Finally, Rhumbline Advisers increased its position in shares of Phibro Animal Health by 0.6% in the fourth quarter. Rhumbline Advisers now owns 76,582 shares of the company's stock worth $1,608,000 after purchasing an additional 484 shares during the last quarter. 99.34% of the stock is owned by hedge funds and other institutional investors.
Phibro Animal Health Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Wednesday, June 4th will be issued a $0.12 dividend. This represents a $0.48 annualized dividend and a dividend yield of 1.94%. The ex-dividend date of this dividend is Wednesday, June 4th. Phibro Animal Health's dividend payout ratio is presently 61.54%.
About Phibro Animal Health
(
Get Free Report)
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
Recommended Stories

Before you consider Phibro Animal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phibro Animal Health wasn't on the list.
While Phibro Animal Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.